Businesswire·2026-02-23 12:09Core Viewpoint - Halper Sadeh LLC is investigating the sale of Arcellx, Inc. to Gilead Sciences, Inc. for $115.00 per share in cash, plus a contingent value right of $5.00 per share based on certain milestones [1] Group 1: Investigation Details - The investigation focuses on whether Arcellx and its board violated federal securities laws and/or breached fiduciary duties by failing to obtain the best possible price for shareholders [2] - Concerns include the fairness of the sales process and potential conflicts of interest, as well as the adequacy of disclosed material information for shareholders to evaluate the transaction [2] Group 2: Potential Actions - Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders [3] - The firm represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [3]